Is a complete SLS research report available?

No complete published report is available for SELLAS Life Sciences Group, Inc. (SLS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

SELLAS Life Sciences Group, Inc. (SLS)

NASDAQ: SLS · USD

$11.3

-1.02 (-8.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SLS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.2B
Net income (ttm)	-29.5M
EPS (ttm)	-$0.23
Shares out	196.6M
Volume	6,728,973
Beta	2.43
Price target	$27.5	+142.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -29.5M
EPS (ttm): -$0.23
Market cap: 2.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SLS indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001390478
Company name	SELLAS Life Sciences Group, Inc.
Country	United States
Country code	US
Cusip	81642T209
Employees	13
Employees Change	-2%
Employees Change Percent	-13.33
Enterprise value	$2.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US81642T2096
Last refreshed	2026-07-25
Market cap	$2.2B
Market cap category	Mid-Cap
Price	$11.32
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	SLS
Website	https://sellaslifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.32%
FCF yield	-1.27%
P/B ratio	20.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-29.5M
Net Income Growth Years	3%
Profit Per Employee	$-2.3M
ROA	-25.45
Roa5y	-96.21
ROCE	-29.21
ROE	-43.58
ROIC	-27.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	515.98%
Cagr3y	88.48%
Cagr5y	5.21%
EPS Growth Quarters	13
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$114.2M
Cash	$107.1M
Current Assets	$111.2M
Current Liabilities	$6.5M
Debt	$871,000
Debt Equity	$0.01
Equity	$107.4M
Liabilities	$6.8M
Long Term Assets	$3M
Long Term Liabilities	$309,000
Net Cash	$106.2M
Net Cash By Market Cap	$4.77
Net Cash Growth	285.9%
Net Debt Equity	$-0.99
Tangible Book Value	$105.5M
Tangible Book Value Per Share	$0.58
WACC	17.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.22
Net Working Capital	$-1.8M
Quick ratio	16.59
Working Capital	$104.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-81.03%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	515.22%
200-day SMA	5.19
3Y total return	569.82%
50-day SMA	10.16
50-day SMA vs 200-day SMA	50over200
5Y total return	28.93%
All Time High	554.5
All Time High Change	-97.96%
All Time High Date	2018-04-03
All Time Low	0.5
All Time Low Change	2,170.36%
All Time Low Date	2024-01-26
ATR	1.34
Beta	2.43
Beta1y	-0.19
Beta2y	0.67
Ch YTD	200.3
High	12.48
High52	15.88
High52 Date	2026-06-30
High52ch	-28.7%
Low	11.22
Low52	1.39
Low52 Date	2025-12-02
Low52ch	714.39%
Ma50ch	11.37%
Premarket Change Percent	-0.57
Premarket Price	$12.27
Premarket Volume	195,076
Price vs 200-day SMA	117.99%
RSI	47.77
RSI Monthly	68.36
RSI Weekly	68.27
Sharpe ratio	2.24x
Sortino ratio	4.06
Total Return	-81.03%
Tr YTD	200.3
Tr1m	24.81%
Tr1w	-14.18%
Tr3m	143.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.05
Operating Income	$-30.4M
Price target	$27.5
Price Target Change	$143

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	195,835,143%
Float Percent	99.59%
Shares Insiders	0.41%
Shares Institutions	27.81%
Shares Out	196,632,574
Shares Qo Q	22.1%
Shares Yo Y	81.03%
Short Float	32.33%
Short Ratio	6.31
Short Shares	32.2

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-30.4M
Average Volume	10,868,214.9x
Bv Per Share	0.59
Ch1m	24.81
Ch1w	-14.18
Ch1y	515.2
Ch3m	144
Ch3y	569.8
Ch5y	28.93
Ch6m	165.7
Change	-8.27%
Change From Open	-8.27
Close	12.34
Days Gap	0
Dollar Volume	76,171,974.4
Earnings Date	2026-08-11
Earnings Time	amc
EBIT	$-31.5M
EBITDA	$-31.5M
EPS	$-0.23
F Score	2
FCF	$-28.2M
FCF EV Yield	-1.33x
FCF Per Share	$-0.14
Financing CF	106,865,000
Fiscal Year End	December
Founded	2,012
Goodwill	1,914,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2019-11-08
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	6.33
Ma150ch	78.77%
Ma20	13.16
Ma20ch	-13.98%
Net CF	78,700,000
Next Earnings Date	2026-08-11
Open	12.34
Optionable	Yes
Position In Range	7.94
Post Close	11.32
Postmarket Change Percent	-0.09
Postmarket Price	$11.31
Ppne	839,000
Pre Close	12.34
Price Date	2026-07-24
Ptbv Ratio	21.09
Relative Volume	0.62x
Share Based Comp	2,249,000
Tr6m	165.73%
Us State	New York
Views	181
Volume	6,728,973

SELLAS Life Sciences Group, Inc. (SLS)

Coverage state: Market snapshot only — no published research

Generate the first SLS analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SLS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SLS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SLS

Frequently asked questions